The prevention of Ebola vaccine will experiment on people by September

ZMapp is the type of drug being tested to prevent Ebola epidemic.

ZMapp is the type of drug being tested to prevent Ebola epidemic. This is the type of drug being exploited on the mice being Ebola exposure. New drugs are tested on monkeys. Recently, the ZMapp are two American patients use and signs.

Who will lower test standards to facilitate the Ebola virus vaccine soon put into use.

Some pharmaceuticals are testing vaccines against Ebola. ZMapp, a type of medication by the American company Mapp Biopharmaceutical Manufacturing, have shown promising results.

ZMapp drugs developed by biotechnology companies pharmaceuticals Biopharmaceutical Mapp, based in San Diego. This company was established in 2003, aims to "develop new drugs aimed at treating and preventing infectious diseases, mainly in order to meet the urgent needs of global health".

Antibodies are proteins used by the immune system to destroy the harmful cells. According to a CNN news source, Brantly and Writebol drugs use is the type of antibodies taken from of mice were Ebola exposure. The blood of the mice were harnessed to the vaccine.

Ebola epidemic.

The World Health Organization (WHO) reported that in September, will conduct the Ebola vaccine vaccine trials on humans. Previously, this vaccine has been tested on apes and achieve good results. Who is hope, this vaccine will be popular and widely used in 2015.=